000 01680 a2200505 4500
005 20250513151740.0
264 0 _c19981028
008 199810s 0 0 eng d
022 _a0275-004X
024 7 _a10.1097/00006982-199807000-00005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOlsen, T W
245 0 0 _aMacular hole surgery using thrombin-activated fibrinogen and selective removal of the internal limiting membrane.
_h[electronic resource]
260 _bRetina (Philadelphia, Pa.)
_c1998
300 _a322-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aContrast Sensitivity
650 0 4 _aEpiretinal Membrane
_xsurgery
650 0 4 _aFemale
650 0 4 _aFibrin Tissue Adhesive
_xadministration & dosage
650 0 4 _aFluorocarbons
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPilot Projects
650 0 4 _aProspective Studies
650 0 4 _aReading
650 0 4 _aRetinal Perforations
_xsurgery
650 0 4 _aThrombin
_xadministration & dosage
650 0 4 _aTissue Adhesives
_xadverse effects
650 0 4 _aTreatment Outcome
650 0 4 _aVisual Acuity
650 0 4 _aVitrectomy
700 1 _aSternberg, P
700 1 _aCapone, A
700 1 _aMartin, D F
700 1 _aLim, J I
700 1 _aGrossniklaus, H E
700 1 _aAaberg, T M
773 0 _tRetina (Philadelphia, Pa.)
_gvol. 18
_gno. 4
_gp. 322-9
856 4 0 _uhttps://doi.org/10.1097/00006982-199807000-00005
_zAvailable from publisher's website
999 _c9695343
_d9695343